Previous Close | 154.39 |
Open | 154.48 |
Bid | 149.33 x 200 |
Ask | 161.67 x 200 |
Day's Range | 149.32 - 154.50 |
52 Week Range | 143.52 - 218.88 |
Volume | |
Avg. Volume | 869,854 |
Market Cap | 18.823B |
Beta (5Y Monthly) | 0.39 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.52 |
Earnings Date | May 02, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 222.59 |
Subscribe to Yahoo Finance Plus to view Fair Value for ALNY
It hasn't been the best quarter for Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) shareholders, since the share price...
CAMBRIDGE, Mass., March 20, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will host a webcast event to discuss results from the KARDIA-2 Phase 2 study of zilebesiran, an investigational RNAi therapeutic targeting liver-expressed angiotensinogen (AGT) in development for the treatment of hypertension, at the American College of Cardiology (ACC) Scientific Session on Sunday, April 7, 2024 at 7:00 pm ET. The event will include pres
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]